Literature DB >> 12220571

Properties of glutaminase of crayfish CNS: implications for axon-glia signaling.

J A Engler1, J M Gottesman, J C Harkins, A K Urazaev, E M Lieberman, R M Grossfeld.   

Abstract

Glutaminase of crayfish axons is believed to participate in recycling of axon-glia signaling agent(s). We measured the activity and properties of glutaminase in crude homogenates of crayfish CNS, using ion exchange chromatography to separate radiolabeled product from substrate. Crayfish glutaminase activity is cytoplasmic and/or weakly bound to membranes and dependent on time, tissue protein, and glutamine concentration. It resembles the kidney-type phosphate-activated glutaminase of mammals in being stimulated by inorganic phosphate and alkaline pH and inhibited by the product glutamate and by the glutamine analog 6-diazo-5-oxo-L-norleucine. During incubation of crayfish CNS fibers in Na(+)-free saline containing radiolabeled glutamine, there is an increased formation of radiolabeled glutamate in axoplasm that is temporally associated with an increase in axonal pH from about 7.1 to about 8.0. Both the formation of glutamate and the change in pH are reduced by 6-diazo-5-oxo-L-norleucine. Our results suggest that crayfish glutaminase activity is regulated by cellular changes in pH and glutamate concentration. Such changes could impact availability of the axon-glia signaling agents glutamate and N-acetylaspartylglutamate. Copyright 2002 IBRO

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220571     DOI: 10.1016/s0306-4522(02)00357-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  GABA and GAD expression in the X-organ sinus gland system of the Procambarus clarkii crayfish: inhibition mediated by GABA between X-organ neurons.

Authors:  Paola Pérez-Polanco; Julieta Garduño; Jorge Cebada; Natanael Zarco; José Segovia; Mónica Lamas; Ubaldo García
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2011-05-31       Impact factor: 1.836

2.  Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors.

Authors:  Ajit G Thomas; Camilo Rojas; Cordelle Tanega; Min Shen; Anton Simeonov; Matthew B Boxer; Douglas S Auld; Dana V Ferraris; Takashi Tsukamoto; Barbara S Slusher
Journal:  Biochem Biophys Res Commun       Date:  2013-07-10       Impact factor: 3.575

3.  Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.

Authors:  Yan Xiang; Zachary E Stine; Jinsong Xia; Yunqi Lu; Roddy S O'Connor; Brian J Altman; Annie L Hsieh; Arvin M Gouw; Ajit G Thomas; Ping Gao; Linchong Sun; Libing Song; Benedict Yan; Barbara S Slusher; Jingli Zhuo; London L Ooi; Caroline G L Lee; Anthony Mancuso; Andrew S McCallion; Anne Le; Michael C Milone; Stephen Rayport; Dean W Felsher; Chi V Dang
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

4.  Small molecule glutaminase inhibitors block glutamate release from stimulated microglia.

Authors:  Ajit G Thomas; Cliona M O'Driscoll; Joseph Bressler; Walter Kaufmann; Camilo J Rojas; Barbara S Slusher
Journal:  Biochem Biophys Res Commun       Date:  2013-11-19       Impact factor: 3.575

Review 5.  Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.

Authors:  Lian Chen; Hengmin Cui
Journal:  Int J Mol Sci       Date:  2015-09-22       Impact factor: 5.923

6.  Glutamine Antagonist JHU-083 Normalizes Aberrant Hippocampal Glutaminase Activity and Improves Cognition in APOE4 Mice.

Authors:  Kristen R Hollinger; Xiaolei Zhu; Elizabeth S Khoury; Ajit G Thomas; Kevin Liaw; Carolyn Tallon; Ying Wu; Eva Prchalova; Atsushi Kamiya; Camilo Rojas; Sujatha Kannan; Barbara S Slusher
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.160

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.